Crawford Investment Counsel Inc Edwards Lifesciences Corp Transaction History

Crawford Investment Counsel Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$106.37 - $130.68 $768,948 - $944,685	-7,229 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $720 - $859	-7 Reduced 0.1%	7,229 $818,000
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $1,509 - $1,885	18 Added 0.25%	7,236 $749,000
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $3,540 - $4,080	45 Added 0.63%	7,218 $604,000
Q4 2020 Feb 01, 2021	BUY	$71.69 - $91.23 $4,301 - $5,473	60 Added 0.84%	7,173 $654,000
Q3 2020 Oct 29, 2020	BUY	$67.19 - $87.44 $11,489 - $14,952	171 Added 2.46%	7,113 $568,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $266,295 - $356,124	4,628 Added 200.0%	6,942 $480,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $104 - $162	-2 Reduced 0.09%	2,314 $436,000
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $143 - $164	2 Added 0.09%	2,316 $540,000
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $142,426 - $174,545	2,314 New	2,314 $509,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Crawford Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Crawford Investment Counsel Inc with notifications on news.